These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 8108794)

  • 21. [Effectiveness of complex treatment of patients with caseous pneumonia].
    Ursov IG; Borovinskiĭ AI; Krasnov VA; Isachenko AV
    Probl Tuberk; 1983 Jul; (7):43-6. PubMed ID: 6634676
    [No Abstract]   [Full Text] [Related]  

  • 22. [Twice-weekly intermittent chemotherapy during the maintenance phase of the short-course treatment for new patients with pulmonary tuberculosis].
    Wada M; Mizoguchi K; Okumura M; Mitarai S; Hoshino H; Ohmori M; Uchimura K; Yoshiyama T; Ogata H
    Kekkaku; 2006 May; 81(5):363-9. PubMed ID: 16768170
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Long-term efficacy of full course intermittent short-course chemotherapy on new smear positive tuberculosis patients].
    Zhonghua Jie He He Hu Xi Za Zhi; 1997 Jun; 20(3):164-6. PubMed ID: 10072822
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Treatment of non-tuberculous pulmonary mycobacteriosis].
    Sakatani M; Nakajima Y
    Kekkaku; 2006 Jan; 81(1):35-50. PubMed ID: 16479999
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Results of brief therapeutic pneumothorax combined with intravenous chemotherapy in new cases of destructive pulmonary tuberculosis].
    Ursov IG; Bolganova MN; Potashova VA; Borovinskaia TA; Gromyko NI
    Probl Tuberk; 1982 Feb; (2):41-5. PubMed ID: 7063478
    [No Abstract]   [Full Text] [Related]  

  • 26. [Long-term results of treatment for drug-resistant pulmonary tuberculosis in socially adapted patients].
    Khodashova ML; Iuditskiĭ MV; Semenova OV
    Probl Tuberk Bolezn Legk; 2004; (3):26-8. PubMed ID: 15338896
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Analysis of short-term effects of short-course intermittent chemotherapies of the World Bank Loaned Project].
    Wen S; Su Y; Zhang F
    Zhonghua Jie He He Hu Xi Za Zhi; 1996 Dec; 19(6):357-9. PubMed ID: 9596819
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Combined chemotherapy of patients with tuberculosis - new regimens and dosage forms].
    Sokolova GB; Koriakin VA; Khalbaeva IV; Elistratova NA; Ziia AV
    Probl Tuberk; 1993; (5):21-3. PubMed ID: 8295879
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Efficacy of treatment for pulmonary tuberculosis with multidrug mycobacterial resistance].
    Mishin VIu; Chukanov VI; Vasil'eva IA
    Probl Tuberk; 2002; (12):18-23. PubMed ID: 12611329
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A controlled clinical trial of oral short-course regimens in the treatment of sputum-positive pulmonary tuberculosis. Tuberculosis Research Centre.
    Int J Tuberc Lung Dis; 1997 Dec; 1(6):509-17. PubMed ID: 9487448
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Colapse therapy in the complex treatment of new cases of destructive pulmonary tuberculosis].
    Salmakhanov AR; Guseĭnov GK; Mutalimov MA
    Probl Tuberk Bolezn Legk; 2009; (3):47-50. PubMed ID: 19455988
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Day hospital as a stage of basic treatment regimen for new cases if pulmonary tuberculosis].
    Lomachenkov VD; Makeenkova LI; Kondrat'eva ZA; Soboleva GM; Argunov AD
    Probl Tuberk; 1997; (5):29-30. PubMed ID: 9454247
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The apex of the lower pulmonary lobe in tuberculosis. VI. Therapeutic management. (a) Intrapleural pneumothorax. (b) Bronchial topical therapy].
    Bignamini A; Briccarello L; Cirillo R; Ferraro U; Pettinati S
    Arch Sci Med (Torino); 1967 Dec; 124(6):630-42. PubMed ID: 5599990
    [No Abstract]   [Full Text] [Related]  

  • 34. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Use of different regimes of etiopathogenetic therapy in pulmonary tuberculosis in adolescents].
    Pavlova MV
    Probl Tuberk; 1995; (5):30-2. PubMed ID: 7567888
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacokinetics of isoniazid in pulmonary tuberculosis--a comparative study at two dose levels.
    Roy V; Tekur U; Chopra K
    Indian Pediatr; 1996 Apr; 33(4):287-91. PubMed ID: 8772902
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Modalities of complex therapy in different categories of patients with pulmonary tuberculosis].
    Krasnov VA; Potashova VA; Naryshkina SL; Kudelia OA
    Probl Tuberk; 2003; (2):27-31. PubMed ID: 12790029
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Maxaquin in the combined treatment of tuberculosis].
    Sokolova GB; Mozhokina GN; Kunichan AD; Elistratova NA; Perel'man MI
    Probl Tuberk; 2000; (5):35-9. PubMed ID: 11077850
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adverse reactions in the conditions of an ab initio intermittent (2/7) administration of antituberculous regimens.
    Corlan E
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1985; 34(2):169-72. PubMed ID: 2999959
    [No Abstract]   [Full Text] [Related]  

  • 40. The early bactericidal activity of anti-tuberculosis drugs: a literature review.
    Donald PR; Diacon AH
    Tuberculosis (Edinb); 2008 Aug; 88 Suppl 1():S75-83. PubMed ID: 18762155
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.